AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 291: F116-F121, 2006. First published January 31, 2006; doi:10.1152/ajprenal.00502.2005
0363-6127/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/1/F116    most recent
00502.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banes-Berceli, A. K.
Right arrow Articles by Marrero, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banes-Berceli, A. K.
Right arrow Articles by Marrero, M. B.

Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells

Amy K. Banes-Berceli,1,2 Sean Shaw,1 Guochuan Ma,3 Michael Brands,2 Douglas C. Eaton,4 David M. Stern,5 David Fulton,1,3 R. William Caldwell,3 and Mario B. Marrero1,3

1Vascular Biology Center, 3Department of Pharmacology and Toxicology, 2Department of Physiology, Medical College of Georgia, Augusta; 4Department of Physiology, Emory University School of Medicine, Atlanta, Georgia; and 5Dean of the University of Cincinnati College of Medicine, Cincinnati, Ohio

Submitted 14 December 2005 ; accepted in final form 23 January 2006

In the current study, we investigated the effect of simvastatin on the ability of high glucose (HG) and ANG II to activate the JAK2-STAT signaling cascade and induce glomerular mesangial cell (GMC) growth. We found that pretreatment with simvastatin significantly inhibited HG- and ANG II-induced collagen IV production, JAK2 activation, and phosphorylation of STAT1 and STAT3 in GMC. We also found that the activation of JAK2 by HG and ANG II was dependent on the Rho family of GTPases. Consistent with these in vitro results, both albumin protein excretion and phosphorylation of JAK2, STAT1, and STAT3 were attenuated in renal glomeruli by administration of simvastatin in a streptozotocin-induced rat model of HG diabetes. This study demonstrates that simvastatin blocks ANG II-induced activation of the JAK/STAT pathway in the diabetic environment, in vitro and in vivo, and, thereby, provides new insights into the molecular mechanisms underlying early diabetic nephropathy.

diabetes; Rho GTPase; nephropathy


Address for reprint requests and other correspondence: M. B. Marrero or R. W. Caldwell, Dept. of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912-2300 (e-mail: mmarrero{at}mcg.edu or wcaldwell{at}mcg.edu)




This article has been cited by other articles:


Home page
 HypertensionHome page
M. Ruperez, R. Rodrigues-Diez, L. M. Blanco-Colio, E. Sanchez-Lopez, J. Rodriguez-Vita, V. Esteban, G. Carvajal, J. J. Plaza, J. Egido, and M. Ruiz-Ortega
HMG-CoA Reductase Inhibitors Decrease Angiotensin II-Induced Vascular Fibrosis: Role of RhoA/ROCK and MAPK Pathways
Hypertension, August 1, 2007; 50(2): 377 - 383.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.